24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study
This study has been completed.
Sponsor:
Centre for Addiction and Mental Health
Collaborator:
Pfizer
Information provided by (Responsible Party):
David Mamo, Centre for Addiction and Mental Health
ClinicalTrials.gov Identifier:
NCT00818298
First received: January 6, 2009
Last updated: July 6, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |